“Survival Rate of Gemcitabine Monotherapy after Prior Platinum-based Chemotherapy for Metastatic Bladder Cancer” (2022) Cermin Dunia Kedokteran, 49(12), hlm. 693–701. doi:10.55175/cdk.v49i12.329.